Important Update on Prescription Forms for TMB and TSBP Licensees

Health & LifestylePublisher's Picks
444

Listen to article (english)

Translate to Spanish or other 102 languages!

Prescribers may consider having Official (CII) Prescription Forms more readily available should there be future events that would impact the ability to e-prescribe. Image for illustration purposes
Prescribers may consider having Official (CII) Prescription Forms more readily available should there be future events that would impact the ability to e-prescribe. Image for illustration purposes

Mega Doctor News

- Advertisement -

 By the Texas Medical Association

As many of our licensees are aware, the recent cyberattack on Change Healthcare has hampered some patients’ ability to obtain certain necessary prescription medications.    

The Texas Medical Board (TMB), in conjunction with the Texas State Board of Pharmacy (TSBP), would like to take this opportunity to remind prescribers that during times when electronic prescribing is unavailable, practitioners are able to utilize the official, physical Schedule II prescription form provided by the TSBP.  These forms may be ordered online via the TSBP’s website at www.pharmacy.texas.gov/PMP/CIIforms.asp.  

- Advertisement -

Prescribers may consider having Official (CII) Prescription Forms more readily available should there be future events that would impact the ability to e-prescribe.   

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Trans Advocacy Group Sues Attorney General in Effort to Hide Incriminating Documents
Next article
How Colorectal Cancer Differs in Younger Adults

More Articles

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

STHS GME Consortium Encourages Community to “Walk with a Doc”, June 6th

Mega Doctor News In an era defined by high-intensity workouts, wearable fitness trackers and advanced training techniques, one of simplest...

STHS Children’s Marks 20th Anniversary with Gala Honoring Pediatric Providers Behind Its Success

For the past 20 years, South Texas Health System Children’s has stood as a place where compassionate care and clinical excellence come together to create hope for children and their families.
- Advertisement -